Loading...

Claire Parker

Title(s)Assistant Professor, Family Health Care Nursing
SchoolSchool of Nursing
AddressRemote Location
Varies 00001
Phone--
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. International consensus to standardise histopathological scoring for small bowel strictures in Crohn's disease. Gut. 2021 May 05. Gordon IO, Bettenworth D, Bokemeyer A, Srivastava A, Rosty C, de Hertogh G, Robert ME, Valasek MA, Mao R, Li J, Harpaz N, Borralho P, Pai RK, Odze R, Feakins R, Parker CE, Guizzetti L, Nguyen T, Shackelton LM, Sandborn WJ, Jairath V, Baker M, Bruining D, Fletcher JG, Feagan BG, Pai RK, Rieder F, Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium . PMID: 33952604.
      View in: PubMed   Mentions:    Fields:    
    2. Standardisation of intestinal ultrasound scoring in clinical trials for luminal Crohn's disease. Aliment Pharmacol Ther. 2021 04; 53(8):873-886. Goodsall TM, Jairath V, Feagan BG, Parker CE, Nguyen TM, Guizzetti L, Asthana AK, Begun J, Christensen B, Friedman AB, Kucharzik T, Lee A, Lewindon PJ, Maaser C, Novak KL, Rimola J, Taylor KM, Taylor SA, White LS, Wilkens R, Wilson SR, Wright EK, Bryant RV, Ma C. PMID: 33641221.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Increased Risk of Infections with Anti-TNF Agents in Patients with Crohn's Disease After Elective Surgery: Meta-Analysis. Dig Dis Sci. 2021 Feb 26. Hanzel J, Almradi A, Istl AC, Yang ML, Fleshner KA, Parker CE, Guizzetti L, Ma C, Singh S, Jairath V. PMID: 33634430.
      View in: PubMed   Mentions:    Fields:    
    4. An international consensus to standardize integration of histopathology in ulcerative colitis clinical trials. Gastroenterology. 2021 Feb 18. Ma C, Sedano R, Almradi A, Casteele NV, Parker CE, Guizzetti L, Schaeffer DF, Riddell RH, Pai RK, Battat R, Sands BE, Rosty C, Dubinsky MC, Rieder F, Harpaz N, Abreu MT, Bryant RV, Lauwers GY, Kirsch R, Valasek MA, Crowley E, Sandborn WJ, Feagan BG, Pai RK, Jairath V. PMID: 33610533.
      View in: PubMed   Mentions:    Fields:    
    5. Systematic Review: Gastrointestinal Ultrasound Scoring Indices for Inflammatory Bowel Disease. J Crohns Colitis. 2021 Jan 13; 15(1):125-142. Goodsall TM, Nguyen TM, Parker CE, Ma C, Andrews JM, Jairath V, Bryant RV. PMID: 32614386.
      View in: PubMed   Mentions:
    6. An expert consensus to standardise the assessment of histological disease activity in Crohn's disease clinical trials. Aliment Pharmacol Ther. 2021 Jan 07. Almradi A, Ma C, D'Haens GR, Sandborn WJ, Parker CE, Guizzetti L, Borralho Nunes P, De Hertogh G, Feakins RM, Khanna R, Lauwers GY, Mookhoek A, Pai RK, Peyrin-Biroulet L, Riddell R, Rosty C, Schaeffer DF, Valasek MA, Singh S, Crowley E, Feagan BG, Jairath V, Pai RK. PMID: 33410551.
      View in: PubMed   Mentions:    Fields:    
    7. Modeling Endoscopic Improvement after Induction Treatment with Mesalamine in Patients with Mild-to-Moderate Ulcerative Colitis. Clin Gastroenterol Hepatol. 2020 Dec 03. Ma C, Jeyarajah J, Guizzetti L, Parker CE, Singh S, Dulai PS, D'Haens GR, Sandborn WJ, Feagan BG, Jairath V. PMID: 33279779.
      View in: PubMed   Mentions:    Fields:    
    8. Novel Documentation of Onset and Rapid Advancement of Pulmonary Arterial Hypertension without Symptoms in BMPR2 Mutation Carriers: Cautionary Tales? Am J Respir Crit Care Med. 2020 12 01; 202(11):1587-1589. Amin EK, Austin ED, Parker C, Colglazier E, Nawaytou H, Leary PJ, Hemnes AR, Teitel D, Fineman JR. PMID: 32692583.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. Clinical Trials of IL-12/IL-23 Inhibitors in Inflammatory Bowel Disease. BioDrugs. 2020 Dec; 34(6):713-721. Almradi A, Hanzel J, Sedano R, Parker CE, Feagan BG, Ma C, Jairath V. PMID: 33105016.
      View in: PubMed   Mentions:
    10. Evaluating the optimum number of biopsies to assess histological inflammation in ulcerative colitis: a retrospective cohort study. Aliment Pharmacol Ther. 2020 11; 52(10):1574-1582. Battat R, Vande Casteele N, Pai RK, Wang Z, Zou G, McDonald JWD, Duijvestein M, Jeyarajah J, Parker CE, Van Viegen T, Nelson SA, Boland BS, Singh S, Dulai PS, Valasek MA, Feagan BG, Jairath V, Sandborn WJ. PMID: 32981088.
      View in: PubMed   Mentions:    Fields:    
    11. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev. 2020 08 28; 8:CD000544. Murray A, Nguyen TM, Parker CE, Feagan BG, MacDonald JK. PMID: 32856298.
      View in: PubMed   Mentions:
    12. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst Rev. 2020 08 12; 8:CD000543. Murray A, Nguyen TM, Parker CE, Feagan BG, MacDonald JK. PMID: 32786164.
      View in: PubMed   Mentions:
    13. Adalimumab for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2020 May 16; 5:CD012877. Townsend CM, Nguyen TM, Cepek J, Abbass M, Parker CE, MacDonald JK, Khanna R, Jairath V, Feagan BG. PMID: 32413933.
      View in: PubMed   Mentions:
    14. Alternative and Complementary Approaches for the Treatment of Inflammatory Bowel Disease: Evidence From Cochrane Reviews. Inflamm Bowel Dis. 2020 05 12; 26(6):843-851. Chande N, Costello SP, Limketkai BN, Parker CE, Nguyen TM, Macdonald JK, Feagan BG. PMID: 31560744.
      View in: PubMed   Mentions:
    15. Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther. 2020 06; 51(11):1047-1066. Dulai PS, Jairath V, Khanna R, Ma C, McCarrier KP, Martin ML, Parker CE, Morris J, Feagan BG, Sandborn WJ. PMID: 32319120.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev. 2020 Jan 27; 1:CD012381. Davies SC, Hussein IM, Nguyen TM, Parker CE, Khanna R, Jairath V. PMID: 31984480.
      View in: PubMed   Mentions:
    17. Anti-IL-12/23p40 antibodies for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2019 Dec 12; 12:CD012804. Davies SC, Nguyen TM, Parker CE, MacDonald JK, Jairath V, Khanna R. PMID: 31828765.
      View in: PubMed   Mentions:
    18. Editorial: evolving histological assessment of NASH. Authors' reply. Aliment Pharmacol Ther. 2019 12; 50(11-12):1245-1246. Pai RK, Feagan BG, Parker CE, Jairath V, Loomba R. PMID: 31709613.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Adalimumab for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2019 11 14; 2019(11). Abbass M, Cepek J, Parker CE, Nguyen TM, MacDonald JK, Feagan BG, Khanna R, Jairath V. PMID: 31742665.
      View in: PubMed   Mentions:
    20. Standardising the interpretation of liver biopsies in non-alcoholic fatty liver disease clinical trials. Aliment Pharmacol Ther. 2019 11; 50(10):1100-1111. Pai RK, Kleiner DE, Hart J, Adeyi OA, Clouston AD, Behling CA, Jain D, Kakar S, Brahmania M, Burgart L, Batts KP, Valasek MA, Torbenson MS, Guindi M, Wang HL, Ajmera V, Adams LA, Parker CE, Feagan BG, Loomba R, Jairath V. PMID: 31583739.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    21. Adverse Events and Nocebo Effects in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Crohns Colitis. 2019 Sep 19; 13(9):1201-1216. Ma C, Panaccione NR, Nguyen TM, Guizzetti L, Parker CE, Hussein IM, Vande Casteele N, Khanna R, Dulai PS, Singh S, Feagan BG, Jairath V. PMID: 31111881.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Pharmacotherapies for the Treatment of Eosinophilic Esophagitis: State of the Art Review. Drugs. 2019 Sep; 79(13):1419-1434. de Rooij WE, Dellon ES, Parker CE, Feagan BG, Jairath V, Ma C, Bredenoord AJ. PMID: 31352605.
      View in: PubMed   Mentions:
    23. Histopathology Scoring Systems of Stenosis Associated With Small Bowel Crohn's Disease: A Systematic Review. Gastroenterology. 2020 01; 158(1):137-150.e1. Gordon IO, Bettenworth D, Bokemeyer A, Srivastava A, Rosty C, de Hertogh G, Robert ME, Valasek MA, Mao R, Kurada S, Harpaz N, Borralho P, Pai RK, Pai RK, Odze R, Feakins R, Parker CE, Nguyen T, Jairath V, Baker ME, Bruining DH, Fletcher JG, Feagan BG, Rieder F. PMID: 31476299.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    24. Reliability of Endoscopic Evaluation of Postoperative Recurrent Crohn's Disease. Clin Gastroenterol Hepatol. 2020 Aug; 18(9):2139-2141.e2. Ma C, Gecse KB, Duijvestein M, Sandborn WJ, Zou G, Shackelton LM, Stitt LW, Parker CE, Bossuyt P, Löwenberg M, Khanna R, Vermeire S, Rutgeerts P, Feagan BG, Jairath V, D'Haens GR. PMID: 31473359.
      View in: PubMed   Mentions:    Fields:    
    25. Response to Placebo, Measured by Endoscopic Evaluation of Crohn's Disease Activity, in a Pooled Analysis of Data From 5 Randomized Controlled Induction Trials. Clin Gastroenterol Hepatol. 2020 May; 18(5):1121-1132.e2. Duijvestein M, Jeyarajah J, Guizzetti L, Zou G, Parker CE, van Viegen T, VandeCasteele N, Khanna R, Van Der Aa A, Sandborn WJ, Feagan BG, D'Haens GR, Jairath V. PMID: 31442599.
      View in: PubMed   Mentions: 1     Fields:    
    26. Letter: pre-operative anti-TNF therapy in Crohn's disease is not associated with increased complications following elective surgery. Aliment Pharmacol Ther. 2019 08; 50(4):467-468. Istl A, Yang ML, Fleshner KA, Parker CE, Guizzetti L, Singh S, Jairath V. PMID: 31359469.
      View in: PubMed   Mentions:
    27. Innovations in Oral Therapies for Inflammatory Bowel Disease. Drugs. 2019 Aug; 79(12):1321-1335. Ma C, Battat R, Dulai PS, Parker CE, Sandborn WJ, Feagan BG, Jairath V. PMID: 31317509.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    28. Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Am J Gastroenterol. 2019 05; 114(5):733-745. Battat R, Duijvestein M, Guizzetti L, Choudhary D, Boland BS, Dulai PS, Parker CE, Nguyen TM, Singh S, Vande Casteele N, Pai RK, Feagan BG, Sandborn WJ, Jairath V. PMID: 30694863.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    29. Assessment of Crohn's disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review. Gut. 2019 06; 68(6):1115-1126. Bettenworth D, Bokemeyer A, Baker M, Mao R, Parker CE, Nguyen T, Ma C, Panés J, Rimola J, Fletcher JG, Jairath V, Feagan BG, Rieder F, Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium. PMID: 30944110.
      View in: PubMed   Mentions:
    30. What is the role of C-reactive protein and fecal calprotectin in evaluating Crohn's disease activity? Best Pract Res Clin Gastroenterol. 2019 Feb - Apr; 38-39:101602. Ma C, Battat R, Khanna R, Parker CE, Feagan BG, Jairath V. PMID: 31327404.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    31. Controversies in Inflammatory Bowel Disease: Exploring Clinical Dilemmas Using Cochrane Reviews. Inflamm Bowel Dis. 2019 02 21; 25(3):472-478. East JE, Boyapati RK, Torres J, Parker CE, MacDonald JK, Chande N, Feagan BG. PMID: 30789982.
      View in: PubMed   Mentions:
    32. Targeting anti-fibrotic pathways in Crohn's disease - The final frontier? Best Pract Res Clin Gastroenterol. 2019 Feb - Apr; 38-39:101603. Ma C, Jairath V, Click B, Hirota SA, Lu C, Parker CE, Rieder F, Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium . PMID: 31327400.
      View in: PubMed   Mentions:
    33. Antibiotics for induction and maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2019 Feb 07; 2:CD012730. Townsend CM, Parker CE, MacDonald JK, Nguyen TM, Jairath V, Feagan BG, Khanna R. PMID: 30731030.
      View in: PubMed   Mentions:
    34. Update on C-reactive protein and fecal calprotectin: are they accurate measures of disease activity in Crohn's disease? Expert Rev Gastroenterol Hepatol. 2019 Apr; 13(4):319-330. Ma C, Battat R, Parker CE, Khanna R, Jairath V, Feagan BG. PMID: 30791776.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    35. Systematic review with meta-analysis: high prevalence and cost of continued aminosalicylate use in patients with ulcerative colitis escalated to immunosuppressive and biological therapies. Aliment Pharmacol Ther. 2019 02; 49(4):364-374. Ma C, Guizzetti L, Cipriano LE, Parker CE, Nguyen TM, Gregor JC, Chande N, Feagan BG, Jairath V. PMID: 30569460.
      View in: PubMed   Mentions:
    36. Systematic review: predictive biomarkers of therapeutic response in inflammatory bowel disease-personalised medicine in its infancy. Aliment Pharmacol Ther. 2018 12; 48(11-12):1213-1231. Stevens TW, Matheeuwsen M, Lönnkvist MH, Parker CE, Wildenberg ME, Gecse KB, D'Haens GR. PMID: 30378142.
      View in: PubMed   Mentions:
    37. Strategies for Detecting Colorectal Cancer in Patients with Inflammatory Bowel Disease: A Cochrane Systematic Review and Meta-Analysis. Am J Gastroenterol. 2018 12; 113(12):1801-1809. Bye WA, Ma C, Nguyen TM, Parker CE, Jairath V, East JE. PMID: 30353058.
      View in: PubMed   Mentions:
    38. A composite disease activity index for early drug development in ulcerative colitis: development and validation of the UC-100 score. Lancet Gastroenterol Hepatol. 2019 Jan; 4(1):63-70. Jairath V, Jeyarajah J, Zou G, Parker CE, Olson A, Khanna R, D'Haens GR, Sandborn WJ, Feagan BG. PMID: 30343116.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. Identifying Outcomes in Clinical Trials of Fistulizing Crohn's Disease for the Development of a Core Outcome Set. Clin Gastroenterol Hepatol. 2019 08; 17(9):1904-1908. Ma C, Parker CE, Nguyen TM, Khanna R, Feagan BG, Jairath V. PMID: 30292887.
      View in: PubMed   Mentions:
    40. Identifying Outcomes in Clinical Trials of Pouchitis for the Development of a Core Outcome Set. Clin Gastroenterol Hepatol. 2019 07; 17(8):1637-1640. Ma C, Athayde J, Davies SC, Parker CE, Nguyen TM, Khanna R, Feagan BG, Jairath V. PMID: 30268563.
      View in: PubMed   Mentions:
    41. The emerging role of histologic disease activity assessment in ulcerative colitis. Gastrointest Endosc. 2018 12; 88(6):887-898. Pai RK, Jairath V, Vande Casteele N, Rieder F, Parker CE, Lauwers GY. PMID: 30142351.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    42. Placebo Rates in Randomized Controlled Trials of Pouchitis Therapy. Dig Dis Sci. 2018 10; 63(10):2519-2528. Athayde J, Davies SC, Parker CE, Guizzetti L, Ma C, Khanna R, Feagan BG, Jairath V. PMID: 29995184.
      View in: PubMed   Mentions:
    43. Heterogeneity in Clinical, Endoscopic, and Histologic Outcome Measures and Placebo Response Rates in Clinical Trials of Eosinophilic Esophagitis: A Systematic Review. Clin Gastroenterol Hepatol. 2018 11; 16(11):1714-1729.e3. Ma C, van Rhijn BD, Jairath V, Nguyen TM, Parker CE, Aceves SS, Furuta GT, Gupta SK, Katzka DA, Safroneeva E, Schoepfer AM, Straumann A, Spergel JM, Pai RK, Feagan BG, Hirano I, Dellon ES, Bredenoord AJ. PMID: 29908360.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    44. Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease. Cochrane Database Syst Rev. 2018 May 12; 5:CD012540. Boyapati RK, Torres J, Palmela C, Parker CE, Silverberg OM, Upadhyaya SD, Nguyen TM, Colombel JF. PMID: 29756637.
      View in: PubMed   Mentions:
    45. Low dose naltrexone for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2018 04 01; 4:CD010410. Parker CE, Nguyen TM, Segal D, MacDonald JK, Chande N. PMID: 29607497.
      View in: PubMed   Mentions:
    46. Heterogeneity in Definitions of Efficacy and Safety Endpoints for Clinical Trials of Crohn's Disease: A Systematic Review. Clin Gastroenterol Hepatol. 2018 09; 16(9):1407-1419.e22. Ma C, Hussein IM, Al-Abbar YJ, Panaccione R, Fedorak RN, Parker CE, Nguyen TM, Khanna R, Siegel CA, Peyrin-Biroulet L, Pai RK, Vande Casteele N, D'Haens GR, Sandborn WJ, Feagan BG, Jairath V. PMID: 29596987.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    47. Efficacy of Medical Therapies for Fistulizing Crohn's Disease: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018 12; 16(12):1879-1892. Lee MJ, Parker CE, Taylor SR, Guizzetti L, Feagan BG, Lobo AJ, Jairath V. PMID: 29374617.
      View in: PubMed   Mentions:
    48. Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis. Cochrane Database Syst Rev. 2018 Jan 16; 1:CD011450. Mohammed Vashist N, Samaan M, Mosli MH, Parker CE, MacDonald JK, Nelson SA, Zou GY, Feagan BG, Khanna R, Jairath V. PMID: 29338066.
      View in: PubMed   Mentions:
    49. Systematic Review: Disease Activity Indices in Eosinophilic Esophagitis. Am J Gastroenterol. 2017 Nov; 112(11):1658-1669. Warners MJ, Hindryckx P, Levesque BG, Parker CE, Shackelton LM, Khanna R, Sandborn WJ, D'Haens GR, Feagan BG, Bredenoord AJ, Jairath V. PMID: 29039850.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    50. Strategies for detecting colon cancer in patients with inflammatory bowel disease. Cochrane Database Syst Rev. 2017 09 18; 9:CD000279. Bye WA, Nguyen TM, Parker CE, Jairath V, East JE. PMID: 28922695.
      View in: PubMed   Mentions:
    51. Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis. Cochrane Database Syst Rev. 2017 09 08; 9:CD011572. Jairath V, Zou GY, Parker CE, MacDonald JK, AlAmeel T, Al Beshir M, Almadi MA, Al-Taweel T, Atkinson NS, Biswas S, Chapman T, Dulai PS, Glaire MA, Hoekman DR, Koutsoumpas A, Minas E, Mosli MH, Samaan M, Khanna R, Travis S, D'Haens G, Sandborn WJ, Feagan BG. PMID: 28886205.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    52. Heterogeneity in Definitions of Endpoints for Clinical Trials of Ulcerative Colitis: A Systematic Review for Development of a Core Outcome Set. Clin Gastroenterol Hepatol. 2018 05; 16(5):637-647.e13. Ma C, Panaccione R, Fedorak RN, Parker CE, Nguyen TM, Khanna R, Siegel CA, Peyrin-Biroulet L, D'Haens G, Sandborn WJ, Feagan BG, Jairath V. PMID: 28843356.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    53. Histologic scoring indices for evaluation of disease activity in Crohn's disease. Cochrane Database Syst Rev. 2017 Jul 21; 7:CD012351. Novak G, Parker CE, Pai RK, MacDonald JK, Feagan BG, Sandborn WJ, D'Haens G, Jairath V, Khanna R. PMID: 28731502.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    54. Development of a core outcome set for clinical trials in inflammatory bowel disease: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey. BMJ Open. 2017 06 09; 7(6):e016146. Ma C, Panaccione R, Fedorak RN, Parker CE, Khanna R, Levesque BG, Sandborn WJ, Feagan BG, Jairath V. PMID: 28601837.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    55. Histologic scoring indices for evaluation of disease activity in ulcerative colitis. Cochrane Database Syst Rev. 2017 May 25; 5:CD011256. Mosli MH, Parker CE, Nelson SA, Baker KA, MacDonald JK, Zou GY, Feagan BG, Khanna R, Levesque BG, Jairath V. PMID: 28542712.
      View in: PubMed   Mentions:
    56. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2016 Oct 26; 10:CD000545. Chande N, Townsend CM, Parker CE, MacDonald JK. PMID: 27783843.
      View in: PubMed   Mentions:
    57. Osmotic and stimulant laxatives for the management of childhood constipation. Cochrane Database Syst Rev. 2016 Aug 17; (8):CD009118. Gordon M, MacDonald JK, Parker CE, Akobeng AK, Thomas AG. PMID: 27531591.
      View in: PubMed   Mentions:
    58. Endoscopic scoring indices for evaluation of disease activity in Crohn's disease. Cochrane Database Syst Rev. 2016 Aug 08; (8):CD010642. Khanna R, Nelson SA, Feagan BG, D'Haens G, Sandborn WJ, Zou GY, MacDonald JK, Parker CE, Jairath V, Levesque BG. PMID: 27501379.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    59. Anti-tuberculous therapy for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2016 Jul 22; 7:CD000299. Patton PH, Parker CE, MacDonald JK, Chande N. PMID: 27444319.
      View in: PubMed   Mentions:
    60. The Next Wave of Biological Agents for the Treatment of IBD: Evidence from Cochrane Reviews. Inflamm Bowel Dis. 2016 07; 22(7):1737-43. Khanna R, Chande N, Vermeire S, Sandborn WJ, Parker CE, Feagan BG. PMID: 27306074.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    61. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev. 2016 May 09; (5):CD000544. Wang Y, Parker CE, Feagan BG, MacDonald JK. PMID: 27158764.
      View in: PubMed   Mentions:
    62. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst Rev. 2016 Apr 21; 4:CD000543. Wang Y, Parker CE, Bhanji T, Feagan BG, MacDonald JK. PMID: 27101467.
      View in: PubMed   Mentions:
    63. Efficient Early Drug Development for Ulcerative Colitis. Gastroenterology. 2016 05; 150(5):1056-1060. Khanna R, Jairath V, Vande Casteele N, Mosli MH, Zou G, Parker CE, Levesque BG, Sandborn WJ, D'Haens G, Feagan BG. PMID: 27018491.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    64. Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis. J Crohns Colitis. 2016 May; 10(5):607-18. Jairath V, Zou G, Parker CE, Macdonald JK, Mosli MH, Khanna R, Shackelton LM, Vandervoort MK, AlAmeel T, Al Beshir M, AlMadi M, Al-Taweel T, Atkinson NS, Biswas S, Chapman TP, Dulai PS, Glaire MA, Hoekman D, Koutsoumpas A, Minas E, Samaan MA, Travis S, D'Haens G, Levesque BG, Sandborn WJ, Feagan BG. PMID: 26746169.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    65. Etrolizumab for induction of remission in ulcerative colitis. Cochrane Database Syst Rev. 2015 Dec 02; (12):CD011661. Rosenfeld G, Parker CE, MacDonald JK, Bressler B. PMID: 26630451.
      View in: PubMed   Mentions:
    66. New Applications for Traditional Drugs in Inflammatory Bowel Disease: What Do Cochrane Reviews Tell Us? Inflamm Bowel Dis. 2015 Dec; 21(12):2948-57. Chande N, Marshall JK, Seow CH, Sandborn WJ, Parker CE, Nelson S, Feagan BG. PMID: 26540276.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    67. The impact of biological interventions for ulcerative colitis on health-related quality of life. Cochrane Database Syst Rev. 2015 Sep 22; (9):CD008655. LeBlanc K, Mosli MH, Parker CE, MacDonald JK. PMID: 26393522.
      View in: PubMed   Mentions:
    Claire's Networks
    Concepts (226)
    Derived automatically from this person's publications.
    _
    Co-Authors (14)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _